Xylem Inc. (NYSE:XYL) Shares Sold by Baldwin Brothers Inc. MA

Share on StockTwits

Baldwin Brothers Inc. MA decreased its stake in Xylem Inc. (NYSE:XYL) by 0.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 79,279 shares of the industrial products company’s stock after selling 230 shares during the period. Baldwin Brothers Inc. MA’s holdings in Xylem were worth $6,669,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the company. Bank of America Corp DE boosted its holdings in shares of Xylem by 0.7% in the 2nd quarter. Bank of America Corp DE now owns 3,174,546 shares of the industrial products company’s stock valued at $206,218,000 after buying an additional 21,340 shares in the last quarter. Bank of New York Mellon Corp raised its position in Xylem by 19.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,692,983 shares of the industrial products company’s stock valued at $109,976,000 after purchasing an additional 281,057 shares during the last quarter. Bank of Montreal Can raised its position in Xylem by 19.2% in the 2nd quarter. Bank of Montreal Can now owns 1,497,305 shares of the industrial products company’s stock valued at $99,601,000 after purchasing an additional 240,978 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in Xylem by 49.1% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,075,135 shares of the industrial products company’s stock valued at $69,841,000 after purchasing an additional 354,020 shares during the last quarter. Finally, Baird Financial Group Inc. raised its position in Xylem by 176.2% in the 2nd quarter. Baird Financial Group Inc. now owns 934,739 shares of the industrial products company’s stock valued at $73,636,000 after purchasing an additional 596,250 shares during the last quarter. Institutional investors and hedge funds own 84.92% of the company’s stock.

Several research firms recently commented on XYL. Rosenblatt Securities reduced their price target on shares of Xylem from $85.00 to $82.00 and set a “buy” rating for the company in a research report on Thursday, July 30th. Jefferies Financial Group upped their price target on shares of Xylem from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Credit Suisse Group upped their price target on shares of Xylem from $62.00 to $69.00 and gave the company an “underperform” rating in a research report on Friday, July 31st. TheStreet upgraded shares of Xylem from a “c+” rating to a “b-” rating in a research report on Monday, September 28th. Finally, Royal Bank of Canada restated a “buy” rating on shares of Xylem in a research report on Sunday, September 13th. Three investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the stock. Xylem presently has a consensus rating of “Hold” and a consensus target price of $72.13.

In related news, SVP David Flinton sold 1,008 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $80.86, for a total value of $81,506.88. Following the sale, the senior vice president now directly owns 25,757 shares of the company’s stock, valued at approximately $2,082,711.02. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Markos I. Tambakeras sold 700 shares of the stock in a transaction dated Friday, October 2nd. The shares were sold at an average price of $85.00, for a total transaction of $59,500.00. Following the completion of the sale, the director now directly owns 43,247 shares in the company, valued at $3,675,995. The disclosure for this sale can be found here. Insiders sold a total of 42,658 shares of company stock valued at $3,657,008 in the last quarter. Insiders own 1.01% of the company’s stock.

Shares of XYL traded up $0.55 during trading hours on Friday, reaching $91.52. The company had a trading volume of 1,506,271 shares, compared to its average volume of 1,253,336. The firm has a 50 day simple moving average of $84.66 and a 200-day simple moving average of $72.95. The company has a current ratio of 2.40, a quick ratio of 1.97 and a debt-to-equity ratio of 1.06. The company has a market capitalization of $16.47 billion, a price-to-earnings ratio of 65.84, a PEG ratio of 4.57 and a beta of 1.07. Xylem Inc. has a 12-month low of $54.62 and a 12-month high of $93.14.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, July 30th. The industrial products company reported $0.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.01. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. Xylem had a net margin of 5.09% and a return on equity of 14.72%. Sell-side analysts forecast that Xylem Inc. will post 1.85 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 3rd. Stockholders of record on Thursday, November 5th will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, November 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.14%. Xylem’s dividend payout ratio is presently 34.44%.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

See Also: What is the price-to-earnings growth (PEG) ratio?

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply